Physician profile
Casey John Kiser
NPI 1174889687
$16,423.78
in general payments reported to CMS, 2019-2025
9 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $300 · 2021: $588 · 2022: $2,818 · 2023: $151 · 2024: $196 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $473.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,157.50 | 2019 | |
| Encore Medical, LP | $4,555.67 | 2019 | |
| Arthrex, INC. | $2,863.51 | 2019-2023 | Arthroplasty Implants Anatomic Total Shoulder Eclipse |
| Novus Surgical Solutions LLC | $1,821.67 | 2020-2022 | |
| Medinc of Texas | $1,133.00 | 2019 | |
| Stryker Corporation | $527.80 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed |
| Exactech, INC. | $302.02 | 2019 | |
| Novus Surgical Consultants | $39.83 | 2024-2025 | |
| Glaxosmithkline, LLC. | $22.78 | 2025 | Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Kiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.